Evaluation of Regulatory B Cells and Serum IL-10 Concentration in Peripheral Blood of Women with Recurrent Pregnancy Loss
Abstract
Background: Although the role of B cells in normal pregnancy has been recently highlighted, their importance and function are not completely clarified. Until now, some investigations have shown that during pregnancy, regulatory B cells (Breg), a subset of B cells, are one of the key players in immune regulation by both producing IL-10 and cell-cell interactions. Therefore, any decrease in the number or function of these cells may lead to recurrent pregnancy loss (RPL). Thus, the objective of this study was to characterize Breg cell frequency and function in women who suffered from RPL in comparison with healthy non-pregnant and pregnant women (under twenty weeks of gestational age) as controls.
Method: In this study, peripheral blood samples of women suffering from RPL (n=8), women with normal pregnancy under 20 weeks of gestational age (n=14), and healthy nonpregnant women (n=10) were collected. The frequency of Breg cells (CD19+CD24hiCD38hi) was measured by flow cytometry. The serum level of the IL-10 cytokine, as a marker of Breg cell function, was measured by ELISA.
Results: The Percentage of Breg cells in women who suffered from RPL was significantly lower than that of women who had normal pregnancies (P=0.0016). The percentages of Breg cells in women who suffered from RPL were also significantly lower than in non-pregnant women (P=0.0001). Furthermore, no significant differences were observed in Breg cell percentages between normal pregnant and non-pregnant women. Evaluation of IL-10 concentration in the serum of women who had participated in this study showed no significant differences between the three groups.
Conclusion: Based on our results, the number of Breg cells was significantly lower in RPL women than in healthy non-pregnant and normal-pregnant women, which shows the significance of these cells in the maintenance of normal pregnancy. However, we could not detect significant differences in the serum levels of IL-10, bringing to mind the notion that the beneficial and supportive function of these cells during pregnancy might be independent of IL-10 secretion. by these cells. Thus, screening of Breg cells in women with pregnancy complications, especially RPL, could be helpful for predicting a healthy pregnancy.
2. Bambang KN, Lambert DG, Lam PM, Quenby S, Maccarrone M, Konje JC. Immunity and early pregnancy events: are endocannabinoids the missing link? J Reprod Immunol. 2012;96(1-2):8-18.
3. Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin North Am. 2015;42(1):117-34.
4. Zenclussen AC. Adaptive immune responses during pregnancy. Am J Reprod Immunol. 2013;69(4):291-303.
5. Lima J, Martins C, Leandro MJ, Nunes G, Sousa M-J, Branco JC, et al. Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study. BMC Pregnancy Childbirth. 2016;16(1):139.
6. Rolle L, Memarzadeh Tehran M, Morell‐García A, Raeva Y, Schumacher A, Hartig R, et al. Cutting edge: IL‐10‐producing regulatory B cells in early human pregnancy. Am J Reprod Immunol. 2013;70(6):448-53.
7. Yang M, Deng J, Liu Y, Ko K-H, Wang X, Jiao Z, et al. IL-10–producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol. 2012;180(6):2375-85.
8. Sattler S, Ling G-S, Xu D, Hussaarts L, Romaine A, Zhao H, et al. IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut. J Autoimmun. 2014;50:107-22.
9. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19+ CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. immunity. 2010;32(1):129-40.
10. Fettke F, Schumacher A, Costa S-D, Zenclussen AC. B cells: the old new players in reproductive immunology. Front immunol. 2014;5:285.
11. Guzman-Genuino RM, Diener KR. Regulatory B cells in pregnancy: lessons from autoimmunity, graft tolerance, and cancer. Front immunol. 2017;8:172.
12. Jensen F, Muzzio D, Soldati R, Fest S, Zenclussen AC. Regulatory B10 cells restore pregnancy tolerance in a mouse model. Biol Reprod. 2013;89(4).
13. Muzzio DO, Ziegler KB, Ehrhardt J, Zygmunt M, Jensen F. Marginal zone B cells emerge as a critical component of pregnancy well-being. Reprod. 2016;151(1):29-37.
14. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221-41.
15. Cheng SB, Sharma S. Interleukin‐10: a pleiotropic regulator in pregnancy. Am J Reprod Immunol. 2015;73(6):487-500.
16. Norris W, Nevers T, Sharma S, Kalkunte S. hCG, preeclampsia and regulatory T cells. Placenta. 2011;32:S182-S5.
17. Robertson SA, Care AS, Skinner RJ. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod. 2007;76(5):738-48.
18. Thaxton JE, Sharma S. Interleukin‐10: a multi‐faceted agent of pregnancy. Am J Reprod Immunol. 2010;63(6):482-91.
19. Piccinni M-P, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med. 1998;4(9):1020.
20. Reyes-Lagos JJ, Peña-Castillo MÁ, Echeverría JC, Pérez-Sánchez G, Álvarez-Herrera S, Becerril-Villanueva E, et al. Women serum concentrations of the IL-10 family of cytokines and IFN-γ decrease from the third trimester of pregnancy to active labor. Neuroimmunomodulation. 2017;24(3):162-70.
21. Bates M, Quenby S, Takakuwa K, Johnson P, Vince G. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum Reprod. 2002;17(9):2439-44.
22. Soheilyfar S, Nikyar T, Fathi Maroufi N, Mohebi Chamkhorami F, Amini Z, Ahmadi M, et al. Association of IL-10, IL-18, and IL-33 genetic polymorphisms with recurrent pregnancy loss risk in Iranian women. Gynaecol Endocrinol. 2019;35(4):342-5.
23. Kaislasuo J, Simpson S, Petersen JF, Peng G, Aldo P, Lokkegaard E, et al. IL‐10 to TNFα ratios throughout early first trimester can discriminate healthy pregnancies from pregnancy losses. Am J Reprod Immunol. 2019.
24. Wąsik M, Nazimek K, Bryniarski K. Regulatory B cell phenotype and mechanism of action–the impact of stimulating conditions. Microbiol Immunol. 2018.
25. Nouel A, Pochard P, Simon Q, Segalen I, Le Meur Y, Pers J, et al. B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner. J Autoimmun. 2015;59:53-60.
26. Lee KM, Stott RT, Zhao G, SooHoo J, Xiong W, Lian MM, et al. TGF‐β‐producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol. 2014;44(6):1728-36.
27. Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, et al. CD19+ CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra23-ra23.
28. Ray A, Basu S, Williams CB, Salzman NH, Dittel BN. A novel IL-10–independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immun. 2012;188(7):3188-98.
29. Mauri C, Menon M. The expanding family of regulatory B cells. Int Immunol. 2015;27(10):479-86.
| Files | ||
| Issue | Vol 6, No 2 (2023) | |
| Section | Original Article | |
| DOI | https://doi.org/10.18502/igj.v6i2.16410 | |
| Keywords | ||
| Regulatory B cell Reproductive Immunology IL-10 RPL | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
